MrsGulyani will be based in Boston (US) and will report to BelénGarijo, President and Chief Executive Officer of Merck Serono.
Merck Serono names Meeta Gulyani as Pharma Executive Committee Head of Strategy and Global Franchises
MrsGulyani will be based in Boston (US) and will report to BelénGarijo, President and Chief Executive Officer of Merck Serono.
Tags
Related posts
- Trial reveals mechanisms that contribute to impact of malnutrition and HIV infection
- Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn
- New NIHR HRC launched for cardiovascular and respiratory medicine
- Study links dementia antipsychotics to higher risks of serious health outcomes
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
